Dr. Shuai Named Associate Medical Director for Flow Cytometry
Wen Shuai, MD, MS, has been promoted to Associate Medical Director for Flow C
Dr. Jones Gives 2 National Presentations
Karra Jones, MD, PhD, recently gave two national presentations:
Pirozzi Promoted to Assistant Professor
Christopher J. Pirozzi, PhD, has been promoted from Medical Instructor to Assistant Professor.
Department Hosts Book Club
Duke Pathology hosted an inaugural Engagement, Culture, and Impact Book Club on June 8, 2022. It was open to everyone in the department.
Dr. Glass Invited to Brigham and Women’s Hospital, Division of Computational Pathology
Carolyn Glass, MD, PhD, was invited to visit with PhD students, post-doctorate and clinical fellows from Harvard University, Massachusetts Institute of Technology, and Brigham and Women’s Hospital during a two-day visit on April 28-29, 2022, to Boston.
Dr. Jones Assumes Muscle & Nerve Pathology Section Head Role
We are pleased to announce that Karra Jones, MD, PhD, was appointed as Section Head of Muscle and Nerve Pathology on May 16, 2022, shortly after joining
Dr. Wang Appointed to NIH Cancer Molecular Pathobiology Study Section
Qianben Wang, PhD, has accepted an invitation to serve as a member of the National Institutes of Health (NIH) Cancer Molecular Pathobiology Study Section (CAMP), Center for Scientific Review (CSR), for a term from July 1, 2022, to June 30, 2026.
Dr. Wang’s LATE Research Published
Shih-Hsiu “Jerry” Wang’s, MD, PhD, latest paper on LATE (Limbic-predominant TDP-43 encephalopathy) was published in Acta Neuropathologica on May 12.